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From Confocal
EndomicroscopyDear Editor:
We enjoyed reading the article by Fritscher-Ravens et al
who showed, by confocal endomicroscopy, that candidate
food antigens caused immediate duodenal mucosa damage
in irritable bowel syndrome (IBS) patients with a prolonged
clinical history of symptoms after meals.1 Their in vivo data
add evidence to the relationship between IBS and food al-
lergy and seem to reinforce our hypothesis that a percent-
age of “nonceliac wheat sensitive” (NCWS)–patients with an
IBS-like clinical presentation could suffer from non–
immunoglobulin E-mediated wheat allergy.2
However, we would suggest that the very high per-
centage of positive confocal laser endomicroscopy patients
(CLE)—22 out of 36—found in the study of Fritscher-
Ravens et al could depend on their inclusion criteria (re-
fractory daily symptoms >1 year, daily shortly after meal
symptoms); in our experience, the frequency of food
hypersensitivity diagnosed by double-blind, placebo-
controlled (DBPC) food challenges in IBS is slightly <30%
(276 patients out of 920).3
Apart from the epidemiologic data, which were not the
objectives of this pilot study, we would like to underline
some aspects of the study and make some suggestions for
future research.
It is interesting that a total of 32 reactions were
analyzed, with different food antigens, in 22 CLE-positive
patients and that the second most frequently offending
food, after wheat, was cow’s milk. This is in keeping with
our data about the high frequency of multiple food hyper-
sensitivities in patients with NCWS. We showed that 206 of
276 NCWS subjects also became symptomatic after DBPC
cow’s milk proteins challenge.3 These observations should
induce the physicians who suspect a relationship between
NCWS or food hypersensitivity and IBS to suggest an elim-
ination diet with the exclusion of more food rather than justwheat, and that the reintroduction should be performed
singly and with great caution, as described.3 In fact, a lack of
response to a wheat-free diet could depend on hypersensi-
tivity to other food antigens which are still included in the
patients’ diet.
We found also of great interest that CLE showed signiﬁ-
cantly higher intraepithelial lymphocyte (IEL) count in CLE-
positive than CLE-negative patients and in controls.
Furthermore, histology showed that themean values of IEL in
CLE-positive patients were 26.4 ± 2.7 per 100 cells. Overall,
this could indicate a state of mucosal inﬂammation owing to
food hypersensitivity. A previous NCWS study which
excluded patients with >25 IEL per 100 EC in the duodenal
mucosa, very probably missed the group of NCWS patients
who had an immunologic pathogenesis at the basis of their
troubles.4 However, in our opinion, NCWS is a heterogeneous
condition,2 which includes different subgroups of patients
and the “allergic hypothesis” does not exclude that, in other
NCWS patients, wheat amylase trypsin inhibitors5 or
fermentable sugars4 could be the main pathogenetic triggers.
Finally, we think that the authors showed that CLE
is an excellent instrument to demonstrate food-related
reactions in IBS and to separate a subgroup of the
NCWS—those with non–immunoglobulin E-mediated
wheat hypersensitivity—from the confuse melting pot that
NCWS still is. However, awaiting a wider diffusion of this
endoscopic means, and taking into account that the eco-
nomic resources are decreasing in developed countries, it
would be very important to correlate the CLE ﬁnding with
simpler, noninvasive biomarkers. In this respect, it would
be interesting to know whether CLE ﬁndings correlate
with the eosinophil cationic protein concentrations in the
stools or with the ﬂow cytometric allergen stimulation
assay results, biomarkers that showed a good concordance
with the DBPC challenge results in IBS patients.6,7
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on our study1 and their thoughts about nonceliac
wheat sensitivity. Recently, there has been increasedinterest in food intolerances (deﬁned as a lack of enzymes to
digest the incriminated food) and sensitivities (involving an
immune reaction to the food) that may trigger symptoms in
patients with irritable bowel syndrome (IBS).1 Although in-
tolerances to lactose or FODMAPs (fermentable oligo- and
disaccharides, monosaccharides and polyols) are dose
dependent and can be deﬁned and treated relatively easily,
identiﬁcation of food sensitivities is more difﬁcult, especially
in case of food allergy.2Moreover, contrary to Carroccio et al’s
suggestion, FODMAPs have never been shown to cause in-
testinal inﬂammation, including intraepithelial lymphocy-
tosis. In contrast, they are considered healthy for gut
homeostasis. Thus, apart from celiac disease which can be
categorized as type IV hypersensitivity to gluten peptides,3
allergic food reactions are either immunoglobulin E (IgE)
mediated via degranulation of mast cells, basophils, and eo-
sinophils, a substantial proportion of food allergies are not
characterized bymarked IgE production and are thus difﬁcult
to diagnose.4 These “atypical” food reactions are commonly
induced by cow’s milk, wheat, egg, and soya,5 and individuals
are frequently sensitive to>1 food. Reaction to food in these
cases seems to be immediate in the majority of patients, as
found in our study. It is therefore likely that most of our 22 of
36 confocal laser endomicroscopy (CLE)-positive patients
had this kind of allergic reaction to the tested foods. However,
as alluded to by Caroccio et al, some of our patients might
have had an immediate reaction to amylase trypsin inhibitors
of wheat (ATIs), which, apart and different from allergic re-
actions, can also elicit an innate immune response in den-
dritic cells andmacrophages of the gut via direct activation of
Toll-like receptor 4,6 an event that is also quick, but slower
than a classical allergic reaction. Interestingly, these ATIs can
both exacerbate adaptive (type IV) and allergic (type I) im-
mune reactions (Zevallos et al, unpublished data). It is thus
possible that both classical food allergens and ATIs contrib-
uted to the observed food sensitivities.
The novelty of our pilot study is the real-time visuali-
zation via CLE of immediate dynamic structural and func-
tional changes in the duodenal epithelium when exposed to
food antigens in a subgroup of IBS patients with suspected
food sensitivities. Our secondary aim and translational proof
of principle was the identiﬁcation of those patients in whom
exclusion of candidate foods might improve symptoms.
The excellent success rate of the exclusion diet based on
CLE ﬁndings provides proof that (1) a subgroup of IBSpatients (likely the w30% of subjects mentioned by Car-
roccio et al) can be classiﬁed as food sensitive and thus be
treated appropriately with an exclusion diet; and (2) these
food sensitivities are possibly nonclassical cases of food
allergies and/or possibly innate reactions to common
nutritional components like wheat ATIs. Thus, CLE now
permits testing select IBS patients for individual food anti-
gens and further elucidation of the immune reactions
involved.
As Carroccio et al correctly stated, this methodology is
currently available only to a few centers. However, we
disagree that this kind of testing for suspected but undiag-
nosed food sensitivities is not cost effective, given the high
costs of unnecessary/noncontributory studies and absence
from work, apart from unnecessary suffering of undiag-
nosed patients.
As to diagnostic protein markers, we recently reported
eosinophilic cationic protein (ECP) and tryptase levels in
duodenal lavage ﬂuid collected at CLE as a measure of
eosinophil and mast cell activation.7 In 13 of 14 CLE-
positive patients, only ECP but not tryptase trended to be
higher than in healthy controls (n ¼ 10). These data suggest
that allergic responses occurred in the majority of these
patients who were all (serum) IgE negative. Because this
response seems to be transient and variable, a much larger
study is required.
We agree that a robust and easy to assess (serum)
biomarker is highly desirable to replace CLE after deﬁned
food challenge, or even the current gold standard of double-
blind placebo-controlled food challenges (DBPC), which are
cumbersome, labor intensive, and usually not reimbursed.
Here, CLE can quickly conﬁrm hypersensitivity reactions to
food antigens and serve as a novel gold standard to develop
noninvasive biomarkers.
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